Newsroom

LEBANON, Ohio--(BUSINESS WIRE)--JBM Packaging, a leading provider of eco-friendly paper packaging and contract packaging services, today celebrated the official opening of its new 52,500-square-foot facility in Lebanon, Ohio. Located approximately one mile from the company’s headquarters, the building is the new home for JBM’s growing contract packaging, kitting and filling services and will employ up to 50 new team members. “This new building signals a strong future for JBM,” said Marcus Shean...

MIAMI--(BUSINESS WIRE)--Palantir Technologies Inc. (NASDAQ: PLTR) today announced that the Army Contracting Command has awarded Palantir USG, Inc. — a wholly-owned subsidiary of Palantir Technologies Inc. — a prime agreement for the production and delivery of the Tactical Intelligence Targeting Access Node (TITAN) ground station system, the Army’s next-generation deep-sensing capability enabled by artificial intelligence and machine learning. The agreement covers the production of eight new TIT...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference. NeuroPace management will participate in a fireside chat discussion on Wednesday, September 9 at 10:55am EDT, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing additional reimbursement for eligible Fee-for-Service Medicare inpatient cases beginning October 1, 2026. Under the Fiscal Year 2027 NTAP program, qualifying inpatient cases involving the Spur Stent System are eligible for an incremental payment up to $2,596.75,...

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on August 31st, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 20,000 shares of common stock to...

BOCA RATON, Fla.--(BUSINESS WIRE)--DigitalBridge Group, Inc. (NYSE: DBRG) (the “Company” or “DigitalBridge”), publicly announced today, in connection with its anticipated acquisition by an affiliate of SoftBank Group Corp. (TSE: 9984, “SoftBank Group”), that it intends to voluntarily withdraw from listing on the New York Stock Exchange (the “NYSE”) and registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s (i) 7.125% Series H Cumul...

CINCINNATI--(BUSINESS WIRE)--Waites announced expanded technology capabilities and solutions to support manufacturing teams in optimizing OEE in the mission to eliminate downtime....

دبي، الإمارات العربية المتحدة، والرياض، المملكة العربية السعودية--(BUSINESS WIRE)--أعلنت اليوم Dhruva، وهي شركة استشارات ضريبية رائدة في الشرق الأوسط، وRyan، وهي مزود عالمي رائد للخدمات والبرمجيات الضريبية، عن انتقال Dhruva إلى العلامة التجارية لشركة Ryan في جميع أنحاء الإمارات العربية المتحدة والمملكة العربية السعودية. ومن المتوقع اكتمال عملية إعادة تسمية العلامة التجارية بحلول نهاية عام 2026، مما يضع أعمال الشركة تحت الهوية العالمية لشركة Ryan، ويعزز مكانتها كجزء من المتخصصين الرائدين عالمياً...

HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the “Fund”) today announced the commencement of a tender offer (“Tender Offer”) beginning September 1, 2026, and expiring at 5:00 p.m. (Eastern) on October 5, 2026, unless the Tender Offer is extended (the “Expiration Date”).The Fund, as announced on April 17, 2026, is offering to acquire up to 25% of its outstanding common shares in exchange for cash at a price equal to 99% of the Fund’s net ass...

SAN DIEGO--(BUSINESS WIRE)--Styx Biotechnologies, Inc., a San Diego-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for solid tumors, today announced a strategic agreement with ZoeNCure Therapeutics Pvt. Ltd. to accelerate selected Styx ADC programs toward first-in-human clinical studies. Under the agreement, Styx will receive an upfront payment and additional milestone-based payments tied to development progress. In exchange, ZoeNCure will provide develop...